India's Zydus Lifesciences reported third-quarter profit above analysts' expectations on Wednesday, driven by strong demand for its generic drugs in its key U.S. market.

Over a hundred companies, including Swiggy and Reliance Power, will announce quarterly earnings. The Indian stock market ...

Zydus Takeda Healthcare Private Limited, a joint venture between Zydus Lifesciences and Takeda Pharmaceutical, celebrates the ...

(MENAFN- IANS) New Delhi, Jan 26 (IANS) Chairman of Zydus Lifesciences ... to nation-building and making India self-reliant in life sciences. This commitment to science, health and innovation ...

Ahmedabad (Gujarat) [India], January 26 (ANI): Chairman of Zydus Lifesciences ... to nation-building and make India self-reliant in life sciences. "This commitment to science, health and ...

Global brokerage Nomura upgraded its rating on drugmaker Zydus Lifesciences to a 'buy' citing higher contribution from diabetes drug Sitagliptin. Accordingly, the firm also raised its price ...

Zydus Lifesciences Ltd share price was down by -3.65% from the previous closing price of ₹957.60. Who are peers of Zydus Lifesciences Ltd? The peers of Zydus Lifesciences Ltd are Sun ...

CVS Caremark will add Zydus' Zituvio and combination products to its template formulary starting January 1, 2025, Zydus Lifesciences Ltd said in a regulatory filing. Template formulary is a ...